3 studies on Insulin secretion mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
The investigation into recombinant human insulin-like growth factor I (IGF-I) as a treatment for hyperinsulinism is significant due to the limitations of existing therapies. If IGF-I effectively reduces insulin secret…
The exploration of ARA 290, a non-hematopoietic erythropoietin analogue, holds significant promise as it targets a novel mechanism for glucose regulation, potentially offering a new therapeutic avenue beyond existing …
While this specific study did not yield results, the initial intent highlights the potential scientific interest in Kisspeptin-10 as a modulator of insulin secretion. If future research successfully demonstrates a rol…